IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
73 hedge funds and large institutions have $55.6M invested in IVERIC bio, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 24 reducing their positions, and 9 closing their positions.
235% more call options, than puts
Call options by funds: $566K | Put options by funds: $169K
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
3% more funds holding
Funds holding: 71 → 73 (+2)
5% less capital invested
Capital invested by funds: $58.3M → $55.6M (-$2.67M)
21% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.61M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.25M |
| 3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$911K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$880K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$838K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$9.84M |
| 2 |
Renaissance Technologies
New York
|
-$717K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$532K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$520K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$498K |
ISEE Hedge Fund Activity: Q2 2018 in Review
73 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2018, worth a combined $55.6M — down 4.6% from $58.3M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new ISEE positions and 9 closed out — a net gain of 2 holders — while 19 added to existing stakes and 24 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $3.61M. The largest seller was Armistice Capital, exiting entirely with an estimated $9.84M sold.
- 73 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2018, up from 71 in Q1 2018.
- Funds reported $55.6M of IVERIC bio, Inc. Common Stock stock for Q2 2018, down 4.6% quarter-over-quarter.
- 11 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2018 and 9 closed out, a net change of +2 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q2 2018 was Sabby Management, an estimated $3.61M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q2 2018 was Armistice Capital, an estimated $9.84M sold.
Based on aggregated 13F filings for Q2 2018.